AB Science fournit un résumé de la conférence virtuelle qui s’est tenue le 16 décembre 2024 COMMUNIQUÉ DE PRESSE AB SCIENCE FAIT LE POINT SUR LA MOLECULE AB8939, UN NOUVEAU DÉSTABILISATEUR DE...
AB Science provides a summary of the webcast held on December 16, 2024 PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON AB8939, A NOVEL MICROTUBULE DESTABILIZER ESCAPING MULTIDRUG RESISTANCE AND...
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON AB8939, A NOVEL MICROTUBULE DESTABILIZER ESCAPING MULTIDRUG RESISTANCE AND STEM CELL TARGETED ALDH INHIBITOR, CURRENTLY IN PHASE 1 Paris, 17 December...
AB Science tiendra une conférence virtuelle le lundi 16 décembre 2024, de 17h30 à 18h30 COMMUNIQUE DE PRESSE AB SCIENCE TIENDRA UNE CONFERENCE VIRTUELLE LE LUNDI 16 DECEMBRE 2024, DE 17H30 A 18H30...
PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY DECEMBER 16, 2024 FROM 5.30PM TO 6.30PM CET Paris, 11 December, 2024, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) will host...
AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY DECEMBER 16, 2024 FROM 5.30PM TO 6.30PM CET...
AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS...
AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN...
PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE THIS DECISION FURTHER STRENGTHENS MASITINIB’S...
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Paris, 17 October, 2024...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.787 | 86.5786578658 | 0.909 | 2.34 | 0.902 | 1166529 | 1.7969161 | DE |
4 | 0.748 | 78.9029535865 | 0.948 | 2.34 | 0.863 | 379578 | 1.71175288 | DE |
12 | 0.796 | 88.4444444444 | 0.9 | 2.34 | 0.77 | 142991 | 1.54176238 | DE |
26 | 0.596 | 54.1818181818 | 1.1 | 2.34 | 0.77 | 81751 | 1.42041774 | DE |
52 | -1.909 | -52.9542302358 | 3.605 | 4.465 | 0.77 | 112630 | 1.93813813 | DE |
156 | -10.704 | -86.3225806452 | 12.4 | 12.5 | 0.77 | 102323 | 4.24284792 | DE |
260 | -4.694 | -73.4585289515 | 6.39 | 21.75 | 0.77 | 148568 | 8.3589427 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.